GHA
CELG

GW Henssler & Associates’s Celgene Corp CELG Stock Holding History

GW Henssler & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,459
Closed -$320K – 208
2019
Q2 		$320K Sell
3,459
-174,801
-98% -$16.6M 0.03% 178
2019
Q1 		$16.8M Sell
178,260
-1,102
-0.6% -$96.4K 1.54% 17
2018
Q4 		$11.5M Sell
179,362
-1,875
-1% -$138K 1.23% 31
2018
Q3 		$16.2M Buy
181,237
+4,810
+3% +$425K 1.48% 22
2018
Q2 		$14M Buy
176,427
+9,799
+6% +$814K 1.37% 25
2018
Q1 		$14.9M Buy
166,628
+3,551
+2% +$341K 1.49% 19
2017
Q4 		$17M Buy
163,077
+1,363
+0.8% +$154K 1.59% 13
2017
Q3 		$23.6M Sell
161,714
-4,953
-3% -$675K 2.37% 5
2017
Q2 		$21.6M Sell
166,667
-546
-0.3% -$66.9K 2.26% 6
2017
Q1 		$20.8M Sell
167,213
-3,029
-2% -$362K 2.25% 6
2016
Q4 		$19.7M Buy
170,242
+571
+0.3% +$63.6K 2.18% 6
2016
Q3 		$17.7M Sell
169,671
-7,978
-4% -$863K 2.03% 9
2016
Q2 		$17.5M Sell
177,649
-1,159
-0.6% -$120K 2.02% 8
2016
Q1 		$17.9M Sell
178,808
-5,749
-3% -$592K 2.1% 8
2015
Q4 		$22.1M Sell
184,557
-11,652
-6% -$1.35M 2.61% 5
2015
Q3 		$21.2M Sell
196,209
-1,656
-0.8% -$206K 2.44% 5
2015
Q2 		$22.9M Sell
197,865
-6,019
-3% -$688K 2.49% 5
2015
Q1 		$23.5M Sell
203,884
-1,711
-0.8% -$204K 2.72% 5
2014
Q4 		$23M Sell
205,595
-5,874
-3% -$619K 2.58% 5
2014
Q3 		$20M Sell
211,469
-2,984
-1% -$269K 2.43% 5
2014
Q2 		$18.4M Sell
214,453
-12,151
-5% -$924K 2.23% 5
2014
Q1 		$15.8M Sell
226,604
-60,296
-21% -$4.77M 1.86% 12
2013
Q4 		$24.2M Sell
286,900
-9,344
-3% -$739K 2.84% 6
2013
Q3 		$22.8M Sell
296,244
-9,538
-3% -$668K 2.95% 5
2013
Q2 		$17.9M Buy
+305,782
New +$18.4M 2.46% 7

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GW Henssler & Associates's CELG Position: Q3 2019 in Review

GW Henssler & Associates sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,459 shares — an estimated $320K sold.

GW Henssler & Associates first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $24.2M in Q4 2013. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • GW Henssler & Associates reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • GW Henssler & Associates sold 3,459 Celgene Corp shares in Q3 2019, an estimated $320K.
  • GW Henssler & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • GW Henssler & Associates's Celgene Corp position peaked at $24.2M in Q4 2013.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on GW Henssler & Associates's 13F filing for Q3 2019, filed 18 Nov 2019.